Abstract:Highlights • First report on the transition of atherosclerosis perception from lipid-centric to chronic inflammatory, revealing a paradigm shift in understanding this global health concern. • This study elucidates the pivotal roles of specific immune cells in the intricate web of events driving the initiation and progression of atherosclerosis, offering a nuanced perspective on disease mechanisms. • Unveiling the complex array of cytokines released by immune cells provides a detailed picture of the atherosclerotic inflammatory landscape, offering potential targets for therapeutic interventions. • Cutting-edge anti-inflammatory strategies showcased in this review, drawn from recent clinical research, illuminate promising avenues for mitigating atherosclerotic cardiovascular diseases. • By dissecting the mechanisms and therapeutic approaches, this study not only contributes to the understanding of atherosclerosis but also outlines a roadmap for future preventive measures and innovative interventions, fostering advancements in cardiovascular health. Introduction Atherosclerosis, traditionally considered a lipid-related disease, is now understood as a chronic inflammatory condition with significant global health implications. Objectives This review aims to delve into the complex interactions among immune cells, cytokines, and the inflammatory cascade in atherosclerosis, shedding light on how these elements influence both the initiation and progression of the disease. Methods This review draws on recent clinical research to elucidate the roles of key immune cells, macrophages, T cells, endothelial cells, and clonal hematopoiesis in atherosclerosis development. It focuses on how these cells and process contribute to disease initiation and progression, particularly through inflammation-driven processes that lead to plaque formation and stabilization. Macrophages ingest oxidized low-density lipoprotein (oxLDL), which partially converts to high-density lipoprotein (HDL) or accumulates as lipid droplets, forming foam cells crucial for plaque stability. Additionally, macrophages exhibit diverse phenotypes within plaques, with pro-inflammatory types predominating and others specializing in debris clearance at rupture sites. The involvement of CD4 + T and CD8 + T cells in these processes promotes inflammatory macrophage states, suppresses vascular smooth muscle cell proliferation, and enhances plaque instability. Results The nuanced roles of macrophages, T cells, and the related immune cells within the atherosclerotic microenvironment are explored, revealing insights into the cellular and molecular pathways that fuel inflammation. This review also addresses recent advancements in imaging and biomarker technology that enhance our understanding of disease progression. Moreover, it points out the limitations of current treatment and highlights the potential of emerging anti-inflammatory strategies, including clinical trials for agents such as p38MAPK, tumor necrosis factor α (TNF-α), and IL-1β, their preliminary outcomes, and the promising effects of canakinumab, colchicine, and IL-6R antagonists. Conclusion This review explores cutting-edge anti-inflammatory interventions, their potential efficacy in preventing and alleviating atherosclerosis, and the role of nanotechnology in delivering drugs more effectively and safely. Graphical abstract Download : Download high-res image (157KB) Download : Download full-size image

Cholesterol Crystal-Mediated Inflammation Is Driven by Plasma Membrane Destabilization.

Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma

Cholesterol crystals in the pathogenesis of atherosclerosis

Intracellular-free calcium dynamics and F-actin alteration in the formation of macrophage foam cells.

Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis

Modeling of Mechanical Stress Exerted by Cholesterol Crystallization on Atherosclerotic Plaques

Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis

Autophagy Plays a Protective Role in Free Cholesterol Overload-Induced Death of Smooth Muscle Cells

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis

Inflammasomes, neutrophil extracellular traps, and cholesterol

Cholesterol binding to VCAM-1 promotes vascular inflammation

Vascular smooth muscle cells in response to cholesterol crystals modulates inflammatory cytokines release and promotes neutrophil extracellular trap formation

Challenges and advances in the management of inflammation in atherosclerosis

Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation

Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death

Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.

The Persistence of Low-Grade Inflammatory Monocytes Contributes to Aggravated Atherosclerosis

The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection

Hegemony of inflammation in atherosclerosis and coronary artery disease

Endothelial Cell-derived Cholesterol Crystals Promote Endothelial Inflammation in Early Atherogenesis

Biomechanics-mediated endocytosis in atherosclerosis